Cancers (May 2021)

Radiomics in Oncology, Part 2: Thoracic, Genito-Urinary, Breast, Neurological, Hematologic and Musculoskeletal Applications

  • Damiano Caruso,
  • Michela Polici,
  • Marta Zerunian,
  • Francesco Pucciarelli,
  • Gisella Guido,
  • Tiziano Polidori,
  • Federica Landolfi,
  • Matteo Nicolai,
  • Elena Lucertini,
  • Mariarita Tarallo,
  • Benedetta Bracci,
  • Ilaria Nacci,
  • Carlotta Rucci,
  • Marwen Eid,
  • Elsa Iannicelli,
  • Andrea Laghi

DOI
https://doi.org/10.3390/cancers13112681
Journal volume & issue
Vol. 13, no. 11
p. 2681

Abstract

Read online

Radiomics has the potential to play a pivotal role in oncological translational imaging, particularly in cancer detection, prognosis prediction and response to therapy evaluation. To date, several studies established Radiomics as a useful tool in oncologic imaging, able to support clinicians in practicing evidence-based medicine, uniquely tailored to each patient and tumor. Mineable data, extracted from medical images could be combined with clinical and survival parameters to develop models useful for the clinicians in cancer patients’ assessment. As such, adding Radiomics to traditional subjective imaging may provide a quantitative and extensive cancer evaluation reflecting histologic architecture. In this Part II, we present an overview of radiomic applications in thoracic, genito-urinary, breast, neurological, hematologic and musculoskeletal oncologic applications.

Keywords